Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.athoracsur.2022.11.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
BioBridge Prosthesis Failure After a Ravitch Repair for Pectus Excavatum.
Ann Thorac Surg
July 2023
Department of Cardiovascular and Thoracic Surgery, Mayo Clinic Arizona, 5777 E Mayo Blvd, Phoenix, AZ 85054. Electronic address:
Structural Failure of the BioBridge Rib Prosthesis After Chest Wall Reconstruction.
Ann Thorac Surg
October 2022
Department of Thoracic Medicine and Surgery, Temple University Hospital, Philadelphia, Pennsylvania; Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania. Electronic address:
Chest wall reconstruction presents a challenging surgical problem with no universally recognized gold standard for the procedure. Various prosthetic and bioprosthetic materials exist for use in chest wall reconstruction, with bioprosthetic materials offering significant advantages in the case of a preoperatively infected surgical field. Here we present a case of the absorbable BioBridge system (Acute Innovations, Hillsboro, OR) used for chest well reconstruction and describe a novel complication of structural failure of the BioBridge plate, involving fracturing of the prosthesis with wound erosion, ultimately requiring reoperation and removal of the device.
View Article and Find Full Text PDFBiobridge: An Outlook on Translational Bioinks for 3D Bioprinting.
Adv Sci (Weinh)
January 2022
Institute for Macromolecular Chemistry, University of Freiburg, Freiburg, 79104, Germany.
3D-bioprinting (3DBP) possesses several elements necessary to overcome the deficiencies of conventional tissue engineering, such as defining tissue shape a priori, and serves as a bridge to clinical translation. This transformative potential of 3DBP hinges on the development of the next generation of bioinks that possess attributes for clinical use. Toward this end, in addition to physicochemical characteristics essential for printing, bioinks need to possess proregenerative attributes, while enabling printing of stable structures with a defined biological function that survives implantation and evolves in vivo into functional tissue.
View Article and Find Full Text PDFNanofibrillar Collagen Scaffold Enhances Edema Reduction and Formation of New Lymphatic Collectors after Lymphedema Surgery.
Plast Reconstr Surg
December 2021
From the Division of Plastic and Reconstructive Surgery, Stanford University; and Stanford Cancer Center.
Background: Treatment of secondary lymphedema remains challenging, with suboptimal rates of edema reduction following physiologic procedures (i.e., lymphaticovenous anastomosis and vascularized lymph node transfer).
View Article and Find Full Text PDFLymphatic regeneration after implantation of aligned nanofibrillar collagen scaffolds: Preliminary preclinical and clinical results.
J Surg Oncol
February 2022
Department of Plastic Surgery, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Background: We tested our hypothesis that implantation of aligned nanofibrillar collagen scaffolds (BioBridge™) can both prevent and reduce established lymphedema in the rat lymphedema model. Our authors report clinical cases that demonstrate new lymphatic formation guided by BioBridge™ as seen by near-infrared (NIR) fluoroscopy and magnetic resonance (MR) lymphography.
Methods: A rat lymphedema model was utilized.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!